The President’s Emergency Plan for AIDS Relief (PEPFAR), the flagship U.S. program combating HIV/AIDS globally, is under threat after allegations surfaced that four nurses in Mozambique performed abortions prohibited under the program’s guidelines.
PEPFAR, established in 2003 and credited with saving over 26 million lives, explicitly bans funding recipients from providing abortion services. However, a recent review revealed that four nurses in Mozambique, where abortion is legal, carried out 21 abortions since January 2021. This marks the first reported violation in the program’s two-decade history, according to U.S. officials.
In a bid to maintain transparency, U.S. officials briefed Congress, emphasizing that measures to ensure compliance with the abortion ban have generally been effective. “It also is an important indication that the compliance measures we have in place have been effective, but could be further strengthened,” a State Department official involved with PEPFAR stated.
The incident has reignited political tensions around the program. Republican Senator Jim Risch, chair of the Senate Foreign Relations Committee, accused the Biden administration of allowing taxpayer dollars to fund abortions and called for an investigation into the Centers for Disease Control and Prevention, one of PEPFAR’s implementing agencies.
“This violation means the future of the PEPFAR program is certainly in jeopardy,” Risch declared, vowing to block any further funding.
Democratic Representative Gregory Meeks countered, warning that using the incident to defund PEPFAR would endanger millions of lives globally. “Using this unfortunate error as a pretext to end funding for PEPFAR… would be a grave mistake,” Meeks said.
PEPFAR’s funding was extended for a year in March 2024, but its long-term reauthorization remains uncertain. With over $100 billion invested since its inception, the program has played a pivotal role in HIV prevention, particularly in regions like Africa, where it helps HIV-infected women deliver virus-free babies through antiretroviral drugs.
Advocates warn that millions of lives could be at risk if PEPFAR is not extended, as political divisions threaten the bipartisan support that has long sustained the program.
